Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIJ has manufactured over 30,000 cell batches in five years. Their BINKIT® platform is widely used for high-purity NK cell expansion for cancer immunotherapy research and preclinical/commercial production. No proprietary therapeutics—but central to clinical studies and manufacturing support for cell therapies[2][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biotherapy Institute of Japan.